Nonalcoholic fatty liver disease (NAFLD) is a widespread cause of
chronic liver disease (CLD) and liver-related morbidity and mortality,
and is the most common cause of CLD in North America. This paper,
the second in a two-part series by Dr Mark DeLegge of NASH
Focus Group addressing nonalcoholic steatohepatitis, provides an
overview of these important diseases.